Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sernova Corp
T.SVA
Alternate Symbol(s):
SEOVF
Healthcare
Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a...
novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(2)
•••
MustangSalley
X
View Profile
View Bullboard History
Comment by
MustangSalley
on May 31, 2022 2:22pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TSX Uplisting Expectations
Excellent questions . Fish, Sva owns all patents and exclusivity for conformal coating worldwide period from University of Miami and from Dr Tomei. Any further improvements to technology belong
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on May 31, 2022 2:21pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TSX Uplisting Expectations
1. I think it is Tomei and her partner(s). If you look at the patents, she is listed, not the university. 2. Exclusive would normally mean exclusive. Never know for sure but I'd guess it is
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(4)
•••
Stockfshr
X
View Profile
View Bullboard History
Comment by
Stockfshr
on May 31, 2022 1:16pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:TSX Uplisting Expectations
Conformal coating questions I emailed Sernova and received no response: I have a few questions about the worldwide exclusive conformal coating commercial licensing agreement that Sernova signed with
...more
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Comment by
Metalsguy1
on May 31, 2022 12:49pm
RE:RE:RE:RE:RE:RE:RE:TSX Uplisting Expectations
My guess is that the DSUs were a last mad dash to get their hands in the cookie jar before new blood coming in would object - Evotec for instance might have raised concerns.
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Post by
BioTeck
on May 31, 2022 12:45pm
ADA2022 Abstract
306-OR - Modified Approach for Improved Islet Allotransplantation into Prevascularized Sernova Cell Pouch Device: Preliminary Results of the Phase I/II Clinical Trial at University of Chicago
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on May 31, 2022 12:33pm
RE:RE:RE:RE:RE:RE:RE:RE:TSX Uplisting Expectations
Post your questions here. Higher chance of them being answered and more accurately.
(4)
•••
Stockfshr
X
View Profile
View Bullboard History
Comment by
Stockfshr
on May 31, 2022 12:01pm
RE:RE:RE:RE:RE:RE:RE:TSX Uplisting Expectations
It doesn't look like an appreciable number of those warrants have been exercised when I look at the latest quarter MD & A. Phoning management for an update is likely useless. I currently have
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on May 31, 2022 11:57am
RE:Vertex Ada Poster
We should all start posting on twitter using the #ADA2022 hashtag. If PR won't do anything, might have to take marketing into our own hands. Just need a few message templates that tell the story
...more
(10)
•••
wj
X
View Profile
View Bullboard History
Post by
wj
on May 31, 2022 11:54am
Installment @2.50 :)
The SVA news post today on the PP is from the exchange simply reflecting the Evotec investment into SVA priced @ 1.57- and that the follow on price for the second instalment is set and fixed &
...more
(2)
•••
MustangSalley
X
View Profile
View Bullboard History
Post by
MustangSalley
on May 31, 2022 9:57am
Vertex Ada Poster
If you look at their poster Hba1c baseline levels for a severe hypoglycaemic are 8.6 and only reduced by one point . Whereas Sva patients had numbers go from 11 to 6 . Vertex does not have really
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on May 31, 2022 9:41am
RE:RE:RE:Vertex Class Action
https://stockhouse.com/news/press-releases/2022/05/31/vertex-to-present-new-data-on-vx-880-clinical-trial-at-82nd-american-diabetes So the trial is only stopped in the USA and continues in Canada.
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on May 31, 2022 2:44am
RE:RE:RE:RE:RE:RE:RE:TSX Uplisting Expectations
Agreed 100 percent. I have no idea why everyone voted in favor of the dsu package. Oh wait I know, because the majority of stock holders are retailers who had no clue what it meant. I hope they learn
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on May 31, 2022 2:40am
RE:RE:RE:RE:RE:RE:TSX Uplisting Expectations
Some of those have already been exercised. You'll have to call in and find out what remains, let us know the result. Could easily be cleaned and absorbed if PR Dept gets their fingers out of each
...more
(2)
•••
MustangSalley
X
View Profile
View Bullboard History
Comment by
MustangSalley
on May 31, 2022 1:16am
RE:RE:RE:RE:RE:RE:TSX Uplisting Expectations
The 38.7 million Dsu for management was not necessary and not justified last year . But Hollar wanted cheap options ... What CFO derserves 5 million options after being on the job less than 2
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >